Periodic Reporting for period 2 - OncoMasTR (OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer)

Breast cancer is the most frequently diagnosed cancer in women (25%) with 1.6 million new cases annually worldwide and increasing by around 1.5% each year. Due to the advent of mammographic screening across the EU and worldwide over the last 30 years, the majority of newly...